Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.

Autor: Walmsley, Sharon1 (AUTHOR), Smith, Don E.2 (AUTHOR), Górgolas, Miguel3 (AUTHOR), Cahn, Pedro E.4 (AUTHOR), Lutz, Thomas5 (AUTHOR), Lacombe, Karine6 (AUTHOR), Kumar, Princy N.7 (AUTHOR), Wynne, Brian8 (AUTHOR), Grove, Richard9 (AUTHOR), Bontempo, Gilda10 (AUTHOR), Moodley, Riya11 (AUTHOR), Okoli, Chinyere11 (AUTHOR), Kisare, Michelle11 (AUTHOR) michelle.o.kisare@viivhealthcare.com, Jones, Bryn11 (AUTHOR), Clark, Andrew11 (AUTHOR), Ait-Khaled, Mounir11 (AUTHOR)
Zdroj: AIDS Research & Therapy. 3/21/2024, Vol. 21 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje